AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
GW Pharmaceuticals (GWPH) stock forecast for 2023
The forecast has been updated: October 14, 2021 5:11
GW Pharmaceuticals stock price online today
Analyst Target Price
201.13Dividend Date
-Ex Dividend Date
-Last Split Factor
NoneLast Split Date
-Should you buy or sell GW Pharmaceuticals stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? GW Pharmaceuticals stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $201.13 target price for GW Pharmaceuticals stock stock.
Today 200 Day Moving Average is the support level (167.56 $).
50 Day Moving Average is the support level (218.22 $).
GWPH Forecast for 2023
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 159.64 | 149.14 | 172.83 | 13.71 % |
| Feb | 174.40 | 156.82 | 187.34 | 16.29 % |
| Mar | 178.06 | 165.84 | 190.02 | 12.72 % |
| Apr | 179.55 | 159.95 | 186.59 | 14.28 % |
| May | 190.11 | 180.26 | 202.35 | 10.92 % |
| Jun | 197.30 | 177.69 | 204.75 | 13.22 % |
| Jul | 185.14 | 179.18 | 194.73 | 7.99 % |
| Aug | 172.70 | 154.81 | 187.21 | 17.31 % |
| Sep | 163.03 | 156.87 | 179.69 | 12.70 % |
| Oct | 162.35 | 145.75 | 170.98 | 14.75 % |
| Nov | 171.66 | 160.37 | 184.40 | 13.03 % |
| Dec | 174.55 | 169.42 | 192.39 | 11.94 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GW Pharmaceuticals stock.
GW Pharmaceuticals overview
GW Pharmaceuticals Address
SOVEREIGN HOUSE, VISION PARK, HISTON, CAMBRIDGE CB24 9BZ, GBMarket Capitalization
6 813 641 000 $EBITDA
-214 163 008PE Ratio
NonePEG Ratio
0.37Dividend Per Share
NoneDividend Yield
0EPS
1.065Quarterly Earnings Growth YOY
0Quarterly Revenue Growth YOY
0.264Trailing PE
0Forward PE
833.33EV To Revenue
11.44EV To EBITDA
84.1652 Week High
219.5752 Week Low
87.0750 Day Moving Average
218.22200 Day Moving Average
167.56Shares Outstanding
31544700Shares Float
30543800Shares Short Prior Month
659630Short Ratio
1.15Percent Insiders
0.196Percent Institutions
80.35GW Pharmaceuticals stock forecast for this year
GW Pharmaceuticals stock forecast for Jan 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 159.64. Positive monthly dynamics of the instrument is expected with 13.708% volatility is expected.
Pessimistic forecast: 149.14
Optimistic: 172.83
GW Pharmaceuticals stock forecast for Feb 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 174.40. Positive monthly dynamics of the instrument is expected with 16.291% volatility is expected.
Pessimistic forecast: 156.82
Optimistic: 187.34
GW Pharmaceuticals stock forecast for Mar 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 178.06. Positive monthly dynamics of the instrument is expected with 12.725% volatility is expected.
Pessimistic forecast: 165.84
Optimistic: 190.02
GW Pharmaceuticals stock forecast for Apr 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 179.55. Positive monthly dynamics of the instrument is expected with 14.280% volatility is expected.
Pessimistic forecast: 159.95
Optimistic: 186.59
GW Pharmaceuticals stock forecast for May 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 190.11. Positive monthly dynamics of the instrument is expected with 10.917% volatility is expected.
Pessimistic forecast: 180.26
Optimistic: 202.35
GW Pharmaceuticals stock forecast for Jun 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 197.30. Positive monthly dynamics of the instrument is expected with 13.220% volatility is expected.
Pessimistic forecast: 177.69
Optimistic: 204.75
GW Pharmaceuticals stock forecast for Jul 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 185.14. Negative monthly dynamics of the instrument is expected with 7.986% volatility is expected.
Pessimistic forecast: 179.18
Optimistic: 194.73
GW Pharmaceuticals stock forecast for Aug 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 172.70. Negative monthly dynamics of the instrument is expected with 17.306% volatility is expected.
Pessimistic forecast: 154.81
Optimistic: 187.21
GW Pharmaceuticals stock forecast for Sep 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 163.03. Negative monthly dynamics of the instrument is expected with 12.702% volatility is expected.
Pessimistic forecast: 156.87
Optimistic: 179.69
GW Pharmaceuticals stock forecast for Oct 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 162.35. Negative monthly dynamics of the instrument is expected with 14.755% volatility is expected.
Pessimistic forecast: 145.75
Optimistic: 170.98
GW Pharmaceuticals stock forecast for Nov 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 171.66. Positive monthly dynamics of the instrument is expected with 13.033% volatility is expected.
Pessimistic forecast: 160.37
Optimistic: 184.40
GW Pharmaceuticals stock forecast for Dec 2023.
Estimated Average Forecasted GW Pharmaceuticals Price: 174.55. Positive monthly dynamics of the instrument is expected with 11.940% volatility is expected.
Pessimistic forecast: 169.42
Optimistic: 192.39
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 116.82 (18.10.2021) | -0.57 % |
 AbbVie Inc.
|
ABBV | 107.43 (18.10.2021) | -1.74 % |
 Aeterna Zentaris Inc.
|
AEZS | 0.6051 (18.10.2021) | 0.13 % |
 Allakos Inc.
|
ALLK | 104.04 (18.10.2021) | -3.20 % |
 Allogene Therapeutics, Inc.
|
ALLO | 15.73 (18.10.2021) | -4.55 % |
 Amgen Inc.
|
AMGN | 203.13 (18.10.2021) | -2.27 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 14.7 (18.10.2021) | -2.78 % |
 Aurora Cannabis Inc.
|
ACB | 6.92 (18.10.2021) | -1.56 % |
 Becton Dickinson and Company
|
BDX | 238.45 (18.10.2021) | -1.12 % |
 Biogen Inc.
|
BIIB | 269.73 (18.10.2021) | -4.08 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 128.99 (18.10.2021) | -3.46 % |
 BioNTech SE
|
BNTX | 261.09 (18.10.2021) | 5.41 % |
 bluebird bio, Inc.
|
BLUE | 21.03 (18.10.2021) | 0.62 % |
 Boston Scientific Corp.
|
BSX | 42.8 (18.10.2021) | -1.38 % |
 Bristol-Myers Squibb Company
|
BMY | 56.94 (18.10.2021) | -2.43 % |
 Canopy Growth Corp.
|
CGC | 13.2 (18.10.2021) | -1.12 % |
 Castle Biosciences, Inc.
|
CSTL | 62.67 (18.10.2021) | -1.43 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 7.91 (15.10.2021) | -2.59 % |
 Eli Lilly and Company
|
LLY | 238.98 (18.10.2021) | 0.46 % |
 Emergent BioSolutions Inc.
|
EBS | 50.41 (18.10.2021) | -0.55 % |
 Exelixis, Inc.
|
EXEL | 21.31 (18.10.2021) | -2.34 % |
 G1 Therapeutics, Inc.
|
GTHX | 12.52 (18.10.2021) | -1.96 % |
 Gilead Sciences, Inc.
|
GILD | 65.9 (18.10.2021) | -2.56 % |
 GlaxoSmithKline plc
|
GSK | 38.65 (18.10.2021) | -0.92 % |
 GoodRx Holdings, Inc.
|
GDRX | 42.06 (18.10.2021) | -0.85 % |
|
GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 64.58 (18.10.2021) | -1.49 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 7.13 (19.10.2021) | 1.57 % |
 Johnson & Johnson
|
JNJ | 160.12 (18.10.2021) | -0.73 % |
 Medtronic plc.
|
MDT | 120.72 (18.10.2021) | -5.50 % |
 Merck & Co., Inc.
|
MRK | 77.15 (18.10.2021) | -1.51 % |
 Moderna, Inc.
|
MRNA | 334.84 (18.10.2021) | 3.28 % |
 Novartis AG
|
NVS | 82.34 (18.10.2021) | -1.19 % |
 Novavax, Inc.
|
NVAX | 166.25 (18.10.2021) | 2.66 % |
 ObsEva SA
|
OBSV | 2.68 (18.10.2021) | -2.19 % |
 OrganiGram Holdings Inc.
|
OGI | 2.36 (19.10.2021) | 6.79 % |
 Pfizer Inc.
|
PFE | 41.32 (18.10.2021) | -0.41 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 543.48 (18.10.2021) | -1.76 % |
 Sanofi
|
SNY | 48.03 (18.10.2021) | -1.68 % |
 Schrodinger, Inc.
|
SDGR | 53.24 (18.10.2021) | -3.83 % |
 Senseonics Holdings, Inc.
|
SENS | 3.29 (18.10.2021) | -0.30 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 6.69 (18.10.2021) | -2.19 % |
 Stryker Corp.
|
SYK | 262.05 (18.10.2021) | -1.60 % |
 Sundial Growers Inc.
|
SNDL | 0.6512 (18.10.2021) | -0.75 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 9.79 (18.10.2021) | 1.14 % |
 Thermo Fisher Scientific Inc.
|
TMO | 588.03 (18.10.2021) | 0.97 % |
 Tilray, Inc.
|
TLRY | 10.07 (18.10.2021) | -1.66 % |
 UnitedHealth Group, Inc.
|
UNH | 424.62 (18.10.2021) | -0.81 % |
 Veeva Systems Inc.
|
VEEV | 310.49 (18.10.2021) | 0.34 % |
|
Zomedica Corp.
|
ZOM | 0.5117 (18.10.2021) | 2.03 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 3.9 (18.10.2021) | -3.94 % |
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.